The Hemochron Response RxDx heparin and protamine dosing system

Area of Science:

• Cardiovascular Surgery
• Anesthesiology
• Hematology

Background:

• Individualized heparin and protamine dosing improves patient outcomes in cardiac surgery.
• The Hemochron RxDx system optimizes anticoagulation management using activated clotting time tests.
• Current systems involve manual calculations or separate calculators, with a need for automated solutions for the Response system.

Purpose of the Study:

• To compare the efficacy of the new Response RxDx software against existing Hemochron 8000 RxDx and Response-PDA RxDx systems.
• To evaluate the automated calculation of heparin and protamine doses using the Response RxDx software.
• To assess the accuracy and user options of the automated Response RxDx system.

Main Methods:

• A study involving 76 cardiac surgery patients across four clinical sites.
• Comparison of Response RxDx software with Hemochron 8000 RxDx and Response-PDA RxDx systems.
• Automated calculation of blood volume, heparin, and protamine doses based on patient data and clotting times.

Main Results:

• Response RxDx showed high correlation for estimated blood volume (r=0.989), bolus heparin (r=0.925), and protamine doses (r=0.900).
• Results from the Response RxDx system were identical (P > 0.05) to the Hemochron 8000 RxDx and Response-PDA RxDx systems.
• The Response RxDx system offers expanded user options and data management capabilities.

Conclusions:

• The Response RxDx software provides accurate and automated anticoagulation management for cardiac surgery.
• This system is equivalent to existing methods while offering enhanced features and user flexibility.
• The Hemochron Response RxDx system represents a comprehensive solution for anticoagulation management in cardiac surgical patients.